Next |
home / stock / impl / impl message board
Subject | By | Source | When |
---|---|---|---|
great news | stocktrademan | investorshub | 05/08/2023 12:27:33 AM |
$IMPL good read | makinezmoney | investorshub | 05/07/2023 12:39:41 AM |
The now up | stock1ace1 | investorshub | 05/03/2023 6:02:23 PM |
$IMPL The gaining last trade up | Jake L | investorshub | 04/27/2023 8:54:05 AM |
$IMPL Price now | TheFinalCD | investorshub | 04/23/2023 4:58:32 AM |
The now up | napoleanrags | investorshub | 04/23/2023 4:57:11 AM |
$IMPL Price now up | biotech_researcher | investorshub | 04/22/2023 2:53:39 AM |
$IMPL just the news we needed | stock1ace1 | investorshub | 04/20/2023 7:07:45 AM |
$IMPL should we be shorting? | biotech_researcher | investorshub | 04/18/2023 9:04:31 AM |
Setting up nice | napoleanrags | investorshub | 06/27/2022 5:42:13 PM |
Looking fabulous | biotech_researcher | investorshub | 06/27/2022 4:25:32 PM |
Impel Pharmaceuticals to Present Trudhesa Data at the | biotech_researcher | investorshub | 06/11/2022 11:23:38 AM |
Biohaven deal shifts target to Impel Pharma as | biotech_researcher | investorshub | 05/15/2022 1:18:43 PM |
Impel NeuroPharma Provides Updates on Trudhesa Launch and | biotech_researcher | investorshub | 01/18/2022 1:51:01 PM |
23 million shares outstanding, 80% institutionally owned. FDA | biotech_researcher | investorshub | 01/15/2022 7:57:26 PM |
My favorite biotech. Totally unknown.. | biotech_researcher | investorshub | 11/09/2021 9:19:44 PM |
$IMPL - Friday Rundown, Monday Expectations | Jake L | investorshub | 09/11/2021 2:11:49 AM |
$IMPL - Thursday Rundown, Friday Expectations | Jake L | investorshub | 09/09/2021 11:37:27 PM |
$IMPL - The Run Starts | Jake L | investorshub | 09/09/2021 7:52:59 PM |
Did anyone find-out what the scam was on Friday? | Pedro2004 | investorshub | 09/05/2021 11:19:43 AM |
News, Short Squeeze, Breakout and More Instantly...
Impel Pharmaceuticals Inc. Company Name:
IMPL Stock Symbol:
NASDAQ Market:
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
Impel Pharmaceuticals Inc. (IMPL) is expected to report for Q3 2023
2023-10-05 09:39:40 ET DENVER, Colo., Oct 5, 2023 ( www.247marketnews.com )- Impel Pharmaceuticals Inc. (NASDAQ: IMPL) stated, this morning, that it is exploring strategic alternatives and plans to consider a wide range of options with a focus on maximizing shareholder value, including ...